(Q81478286)

English

Large interindividual differences in cellular sensitivity to calicheamicin may influence gemtuzumab ozogamicin response in acute myeloid leukemia

scientific article published on 19 June 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Large interindividual differences in cellular sensitivity to calicheamicin may influence gemtuzumab ozogamicin response in acute myeloid leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

B F Goemans

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

C M Zwaan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S J H Vijverberg

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A H Loonen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

U Creutzig

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

K Hählen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

D Reinhardt

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

B E S Gibson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J Cloos

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

G J L Kaspers

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

19 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

2284-2285

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563175%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.147

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.147

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsets

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.147

7 January 2021

based on heuristic

inferred from DOI database lookup

CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.147

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81478286&oldid=2221109588"